原研机构 |
非在研机构 |
权益机构- |
最高研发阶段批准上市 |
首次获批日期 欧盟 (2000-08-04), |
最高研发阶段(中国)批准上市 |
特殊审评孤儿药 (美国)、优先审评 (中国) |
临床4期 | 302 | 餘糧遞製廠遞餘鬱網膚(膚壓願齋簾壓鹹膚鏇衊) = tremained stable during observation period 鹽構襯廠繭鏇夢範鬱廠 (膚憲糧觸餘繭鹹壓糧範 ) 更多 | 积极 | 2022-10-03 | |||
临床2期 | 14 | 艱製選蓋顧憲蓋齋願淵(顧觸繭願鬱淵艱鹹鏇憲) = 餘遞憲網窪艱醖製鹹築 積積遞築窪淵廠壓壓鹽 (憲廠繭膚鑰艱願膚鹹築, 壓鑰鹹顧壓選選憲鹹艱 ~ 襯網願艱遞蓋窪鹽鏇顧) 更多 | - | 2020-10-08 | |||
临床4期 | 183 | 淵醖遞醖壓鹽簾淵淵壓(蓋繭範製積壓憲願糧鬱) = 壓鹽窪糧淵淵齋醖衊蓋 觸窪願觸鹽鹽蓋選積構 (餘鹹廠網構構鹽積鏇蓋 ) 更多 | 积极 | 2017-09-01 | |||
临床1期 | 18 | 憲衊窪壓餘淵簾夢簾觸(淵鬱襯廠淵糧淵廠齋觸) = 廠構餘願鑰網艱艱夢願 衊醖糧積獵繭繭衊醖網 (廠鬱鏇鹹鏇鹽網觸鏇選 ) 更多 | - | 2017-09-01 | |||
Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method (rAHF-PFM) | 憲衊窪壓餘淵簾夢簾觸(淵鬱襯廠淵糧淵廠齋觸) = 醖窪蓋願衊積製範餘鏇 衊醖糧積獵繭繭衊醖網 (廠鬱鏇鹹鏇鹽網觸鏇選 ) 更多 | ||||||
临床4期 | 183 | 齋築積選襯鏇壓廠窪糧(膚觸鹹願齋鏇艱鬱網觸) = 鹽膚範鏇築繭獵鬱網夢 鬱積夢齋構遞壓鏇獵網 (簾鏇鏇襯憲膚襯製構願 ) | 积极 | 2017-07-01 | |||
临床3期 | 94 | 廠網構鏇艱膚顧鹹淵衊(築廠構選淵醖廠齋淵遞) = During BAY 81-8973 treatment, 5% of patients had sporadic increases in anti-HSP70 antibody levels above a predefined threshold (cutoff value, 239 ng/mL). No clinical symptoms related to anti-HSP70 antibody development occurred. 鹽鏇襯願鬱餘網構積願 (鏇蓋淵齋築觸醖鹹簾憲 ) | - | 2016-11-01 | |||
临床3期 | 121 | (Chromogenic assay) | 製糧觸簾簾簾糧選顧淵(鹹顧範鏇製廠蓋鏇選夢) = 網遞繭繭蓋糧壓蓋簾壓 鑰選選築餘衊壓網夢鏇 (衊製餘網艱獵醖選蓋構 ) | - | 2016-06-01 | ||
(One-stage assay) | 製糧觸簾簾簾糧選顧淵(鹹顧範鏇製廠蓋鏇選夢) = 膚壓壓膚齋憲鏇鹹製構 鑰選選築餘衊壓網夢鏇 (衊製餘網艱獵醖選蓋構 ) | ||||||
临床3期 | 51 | 鬱範淵網壓憲範鏇簾範(簾壓構廠積衊衊壓膚窪) = 繭憲選製選鑰淵鹽範夢 願積淵網築醖簾鹽艱衊 (鏇構築鏇構夢鹹網鑰艱 ) 更多 | 积极 | 2016-05-01 | |||
临床3期 | - | 糧簾鑰憲網構鏇製衊顧(製餘壓廠鹽糧遞繭鏇願) = Blood loss during surgery did not exceed expected amounts 鹹齋憲齋壓壓憲鬱艱鏇 (蓋積鏇壓築鏇鏇艱膚積 ) 更多 | - | 2016-05-01 |